Tertiary hyperparathyroidism in a patient with autosomal dominant pseudohypoparathyroidism type 1b
Background: Pseudohypoparathyroidism type 1b (PHP1b) is a rare genetic disorder characterized by renal parathyroid hormone (PTH) resistance. While chronic secondary hyperparathyroidism is common, progression to autonomous tertiary hyperparathyroidism remains exceptionally rare, with only five cases reported in the literature. Case description: We report the case of a 66-year-old Caucasian woman with an autosomal dominant form of PHP1b (maternal transmission of a STX16 gene deletion) diagnosed at age 35. After 31 years of stable disease managed with calcitriol, she presented with persistent hypercalcemia for 5 years. Longitudinal follow-up revealed a dramatic, tenfold surge in serum intact PTH levels, peaking at 932 ng/l. Physical examination showed a mildly rounded facies and brain imaging revealed basal ganglia calcifications. A neck ultrasound and technetium-99m sestamibi scintigraphy confirmed a right medial parathyroid nodule. The patient underwent surgical resection of the lesion. Histopathology confirmed a follicular parathyroid adenoma. Postoperatively, serum calcium and PTH levels normalized rapidly and remained stable at 6-month follow-up. Conclusion: Tertiary hyperparathyroidism is a rare but critical long-term complication of PHP1b that typically occurs after decades of stimulation. In patients with PHP1b, the onset of hypercalcemia accompanied by a significant, progressive increase in PTH levels should immediately raise suspicion of an autonomous parathyroid adenoma and prompt targeted imaging and surgical management.
Authors
- Xavier Vandemergel (ORCID: https://orcid.org/0000-0002-3939-708X)
Institutions
- Epicura (BE)
Publication Details
- Journal
- European Journal of Case Reports in Internal Medicine
- Published
- 2026-11-20
- DOI
- https://doi.org/10.12890/2026_007581
- Primary Topic
- Parathyroid Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00